axsometherapeuticsinc.gcs-web.com Open in urlscan Pro
2a02:26f0:3500:88f::2b39  Public Scan

Form analysis
0 forms found in the DOM

Text Content

Skip to main navigation
 * About Axsome About Axsome
     About Axsome
   * AllAll
   * Overview
   * Management Team
   * Board of Directors
   * Intellectual Property
   * State Disclosures
 * Portfolio Portfolio
     Portfolio
   * AllAll
   * Products Overview   Products Overview  
       Products Overview
     * AllAll
     * Overview
     * Sunosi® (solriamfetol)
   * Pipeline Overview   Pipeline Overview  
       Pipeline Overview
     * AllAll
     * Overview
     * AXS-05
     * AXS-07
     * AXS-12
     * AXS-14
 * Conditions Conditions
     Conditions
   * AllAll
   * Overview
   * Depression
   * Migraine
   * Alzheimer’s
     Disease Agitation
   * Excessive Daytime
     Sleepiness
   * Narcolepsy
   * Fibromyalgia
   * Smoking Cessation
 * 
 * Science Science
     Science
   * AllAll
   * Overview
   * Medical Information U.S.
   * Medical Information International
   * Publications
 * Investors Investors
     Investors
   * AllAll
   * Overview
   * Corporate Governance
   * Stock Information
   * Financial Information
   * News & Events
   * Webcasts &
     Presentations
   * Analyst Coverage
   * Shareholder Services
   * Email Alerts
 * Careers Careers
     Careers
   * AllAll
   * Overview
   * Current Opportunities


INVESTOR
RELATIONS


INVESTORS


INVESTORS


NASDAQ: AXSM

$91.76 +2.52 (+2.82%)


Minimum 15 minutes delayed. Source:

Featured Events
November 12, 2024 at 8:00 AM EST
Axsome Third Quarter 2024 Financial Results
Click here for webcast


See all Events
Recent News

October 29, 2024

Axsome Therapeutics Presents Data from Multiple Programs Spanning Its Innovative
Neuroscience Portfolio at Psych Congress 2024

Click here to read more

October 15, 2024

Axsome Therapeutics to Report Third Quarter 2024 Financial Results on November
12

Click here to read more

September 24, 2024

Axsome Therapeutics Presents Data from Multiple Programs at Sleep Europe 2024

Click here to read more


See all News


EMAIL ALERTS


CLICK HERE TO SUBSCRIBE TO AXSOME THERAPEUTICS EMAIL ALERTS.

Subscribe here

 * About Axsome About Axsome
   * AllAll
   * Overview
   * Management Team
   * Board of Directors
   * Intellectual Property
   * State Disclosures
 * Portfolio Portfolio
   * AllAll
   * Products Overview
   * Products Overview
   * Auvelity™ (dextromethorphan-bupropion)
   * Sunosi® (solriamfetol)
   * Pipeline Overview
   * AXS‑05
   * AXS‑07
   * AXS‑12
   * AXS‑14
 * Conditions Conditions
   * AllAll
   * Overview
   * Depression
   * Migraine
   * Alzheimer's
     Disease Agitation
   * Excessive Daytime
     Sleepiness
   * Narcolepsy
   * Fibromyalgia
   * Smoking Cessation
 * 
 * Science Science
   * AllAll
   * Overview
   * Medical Information U.S.
   * Medical Information International
   * Publications
 * Investors Investors
   * AllAll
   * Overview
   * Corporate Governance
   * Stock Information
   * Financial Information
   * News & Events
   * Webcasts &
     Presentations
   * Analyst Coverage
   * Shareholder Services
   * Email Alerts
 * Careers Careers
   * AllAll
   * Careers
   * Current Opportunities

 * Contact Us
 * Privacy Notice
 * Terms of Use
 * 
 * 

© 2024 Axsome Therapeutics, Inc. All rights reserved. One World Trade Center,
22nd Floor, New York, NY 10007 info@axsome.com